Titolo	Data di pubblicazione	Autore(i)
1	X-linked Charcot-Marie-Tooth polyneuropathy due to mutation of the connexin-32 gene: revision of our cases of genetic neuropathies and identification of three affected families.	2003	Vercelli M; Mongini T; Pasini B; Cocito D; Benna P; Benetton G; Mutani R; Palmucci L.
2	What’s ALS? ALS clinical phenotypes in an Italian register	2010	Chio’ A; Calvo A; Mazzini L; Bottacchi E; Moglia C; Balma M; Gallo S; Canosa A; Mutani R; Mora G
3	Weight loss is the best marker of malnutrition in ALS: a prospective study	2008	Giacone S, Ilardi A, Moglia C, Cammarosano S, De Mercanti S, Ghiglione P, Calvo A, Pessia A, Mutani R; Chio' A
4	Vascular adhesion molecules expression, inflammation and neurodegeneration in ALS CNS tissue	2009	Vercellino M; Votta B; Grifoni S; Merola A; Masera S; Chio' A; Mutani R; Cavalla P; Giordana MT
5	Validity of hospital morbidity records for amyotrophic lateral sclerosis. A population-based study	2002	Chiò A; Ciccone G; Calvo A; Vercellino M; Di Vito N; Ghiglione P; Mutani R; Plano F; Bertolotto A; Bottacchi E; Cocito D; Giordana MT; Leone M; Mazzini L; Mora G; Terreni A; Schiffer D; Bergamasco B; Rainero I; Tribolo A; Sciolla R; Mondino F; Gaviani P; Monaco F; De Mattei M; Morgando E; Sosso L; Gionco M; Morino U; Nobili M; Appendino L; Mazzini L; Piazza D; Oddenino E; Liboni W; Vaula G; Ferrari G; Favero M; Doriguzzi Bozzo C; Santamaria P; Massazza U; Bollani E; Villani A; Conti R; Balzarini C; Palermo M; Vergnano F; Cordera S; Buffa C; Penza MT; Fassio F; Meineri P; Cognazzo A; Mocellini C; Dutto A; Cucatto A; Cavestro C; Troni W; Corso G
6	[Usefulness of neuropsychological studies in the documentation of functional damage in a case of deep frontal lesion]	1991	BELTRAMI S ;MORTARA F ;MUTANI R ;TERAZZI E
7	[Use of taurine in experimental epilepsy induced with cobalt-alumina]	1974	MUTANI R ;DELSEDIME M ;DURELLI L ;FARIELLO R
8	[Use of a new method of instrumental evaluation of the kinetic deficity in parkinsonism]	1970	MUTANI R ;FARIELLO R
9	Unusual manifestation of hereditary neuropathy with liability to pressure palsy.	1982	TRACCIS S ;PIRISI A ;MUTANI R
10	Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients.	1999	BERTOLOTTO A ;CAPOBIANCO M ;MALUCCHI S ;MANZARDO E ;AUDANO L ;BERGUI M ;BRADAC GB ;MUTANI R
11	Transforming growth factor beta 1 (TGF beta 1) mRNA level correlates with magnetic resonance imaging disease activity in Multiple Sclerosis patients	1999	A. Bertolotto; M. Capobianco; S. Malucchi; E. Manzardo; L. Audano; M. Bergui; G. B. Bradac; R. Mutani
12	Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy	2010	Chiò A; Calvo A; Ghiglione P; Mazzini L; Mutani R; Mora G; PARALS
13	Tracheostomy in ALS: a 10-year population-based study in Italy	2009	Calvo A; Ghiglione P; Moglia C; Balma M; Pessia A; Giacone S; Mora G; Mutani R; Chio' A
14	Tracheostomy in ALS: a 10-year population-based study in Italy	2008	Chio' A; Mora G; Calvo A; Mazzini L; Bottacchi E; Mutani R
15	Tooth loss and obstructive sleep apnoea	2006	BUCCA C; CICOLIN A; BRUSSINO L; ARIENTI A; GRAZIANO A; EROVIGNI F; PERA P; GAI V; MUTANI R; PRETI G; ROLLA G; CAROSSA S
16	Therapy of myotonia. Electromyographic evaluation of acute effects of taurine.	1981	DURELLI L ;FASSIO F ;PIREDDA S ;MUTANI R
17	[Therapeutic use of the new benzodiazepine, Ro 5-4023, in the Ramsay-Hunt syndrome]	1971	MUTANI R ;FARIELLO R ;LIBONI W ;QUATTROCOLO G
18	[The use of 'Mogadon' in myoclonic cerebellar dyssynergia. Comparative clinical considerations on benzodiazepine derivatives]	1970	BERGAMASCO B ;FERRARI G ;MUTANI R ;RICCIO A
19	The treatment of myotonia: evaluation of chronic oral taurine therapy.	1983	DURELLI L ;MUTANI R ;FASDURELLI L ;MUTANI R ;FASSIO F
20	The quantification of myotonia. A problem in the evaluation of new antimyotonic drugs.	1983	DURELLI L ;MUTANI R ;PIREDDA S ;FASSIO F ;DELSEDIME M